Infusion Therapy Devices Market Size Forecast To Achieve $21.82 Billion By 2030 With 10.3% CAGR

Global Infusion Therapy Devices Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Infusion Therapy Devices Market Change Between 2026 And 2030?

The infusion therapy devices market has demonstrated rapid expansion in recent years. It is anticipated to grow from $13.33 billion in 2025 to $14.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. Historically, this market’s growth has been fueled by the increasing prevalence of chronic diseases, a rise in hospital admissions requiring infusion therapy, the expansion of oncology and diabetes treatments, the growing application of intravenous drug delivery, and enhanced availability of infusion devices.

The infusion therapy devices market size is projected to experience swift expansion over the coming years, with expectations to reach $21.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. This growth during the forecast period can be attributed to several factors, including the escalating demand for home healthcare services, the growing acceptance of connected medical devices, the broader application of personalized medicine delivery, a heightened emphasis on minimizing medication errors, and increased financial commitments towards smart hospital infrastructure. Key trends anticipated over the forecast period encompass the wider utilization of smart infusion pumps, a surge in the need for portable and ambulatory infusion devices, the expanding incorporation of dose error reduction systems, the growth of home-based infusion therapy, and a stronger emphasis on ensuring patient safety and effective monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

Which Drivers Are Advancing The Infusion Therapy Devices Market Growth?

The rising occurrence of chronic illnesses is anticipated to boost the expansion of the infusion therapy devices market in the future. Chronic diseases are defined as enduring health conditions lasting at least a year, necessitating continuous medical care or restricting daily activities. This increase in chronic disease prevalence stems from factors like unhealthy lifestyle choices, inactive routines, poor dietary habits, and environmental impacts, alongside a surge in risk elements such as obesity, smoking, and stress. Infusion therapy devices play a crucial role in managing chronic conditions by facilitating the accurate and regulated administration of medications and fluids straight into the bloodstream. This method ensures consistent and effective treatment for ailments including diabetes, autoimmune disorders, and cancer, leading to better patient outcomes, increased convenience, and fewer hospital visits. As an illustration, data from the US-based National Library of Medicine, the National Center for Biotechnology Information (NCBI), published in January 2023, predicts a substantial increase of 99.5% by 2050 in individuals aged 50 and older suffering from at least one chronic illness, climbing from 71.522 million in 2020 to 142.66 million. Consequently, the expanding incidence of chronic diseases is a key factor propelling the growth within the infusion therapy devices market.

How Are Different Segment Groups Identified Within The Infusion Therapy Devices Market?

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

Which Trends Are Supporting The Evolution Of The Infusion Therapy Devices Market?

Leading firms within the infusion therapy devices market are concentrating on creating advanced solutions, particularly pressure-enabled drug delivery (PEDD) technology, to improve how liver and pancreatic tumors are treated. PEDD, or pressure-enabled drug delivery, is a method that employs pressure to boost the delivery of therapeutic agents into tissues or organs, especially beneficial in regions where standard approaches might be less effective. As an example, in November 2024, TriSalus Life Sciences, a medical technology firm based in the US, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters. This launch expanded its pressure-enabled drug delivery (PEDD) offerings, aiming to optimize therapeutic administration, thereby broadening treatment choices and potentially bettering patient results. The TriNav LV Infusion System provides distinct features like accommodating larger blood vessels, ranging from 3.5 to 5.0 mm, which extends the application of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a wider patient demographic. This introduction broadens PEDD device compatibility from 1.5 mm to 5.0 mm vessels, providing interventional radiologists with an increased array of treatment possibilities. The TriGuide Guiding Catheters are characterized by a larger inner diameter, a smooth, lubricious lining, and a reverse curve design, facilitating easier femoral access and boosting procedural efficiency. Initial users have reported a 97% satisfaction rate, underscoring the system’s efficacy and user-friendliness in oncology treatments.

Which Key Players Are Active In The Infusion Therapy Devices Market?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated

Access The Complete Infusion Therapy Devices Market Report:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Which Region Accounts For The Highest Share Of The Infusion Therapy Devices Market?

North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Infusion Therapy Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2026, By The Business Research Company

Cigarette Filters Market Report 2026

https://www.thebusinessresearchcompany.com/report/cigarette-filters-global-market-report

Bag Filter Market Report 2026

https://www.thebusinessresearchcompany.com/report/bag-filter-global-market-report

Filters Market Report 2026

https://www.thebusinessresearchcompany.com/report/filters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model